Evolent Health Inc Cash Flow Conversion Efficiency
Evolent Health Inc cash flow conversion efficiency. Based on the latest financial reports, Evolent Health Inc (EVH) has a cash flow conversion efficiency ratio of -0.002x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-984.00K) by net assets ($396.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Evolent Health Inc (2012–2025)
Cash flow conversion efficiency of Evolent Health Inc from 2012 to 2025. This chart illustrates how Evolent Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Evolent Health Inc share price for real-time trading data and today's change.
Evolent Health Inc Cash Flow Conversion Ratio Explained
Evolent Health Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Evolent Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Evolent Health Inc ranked by their cash flow conversion efficiency. Also see Evolent Health Inc (EVH) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Penyao Environmental Protection Co Ltd Class A
SHE:300664
|
0.023x |
|
Chun Yuan Steel Industry Co Ltd
TW:2010
|
0.019x |
|
Globalworth REIT
LSE:GWI
|
0.013x |
|
Sligro Food Group NV
AS:SLIGR
|
-0.090x |
|
Harbin Medisan Pharmaceutical Co Ltd
SHE:002900
|
-0.008x |
|
Compania General de Electricidad SA
SN:CGE
|
-0.004x |
|
Beijing Comens New Materials
SHE:300200
|
-0.004x |
|
Yieh United Steel
TWO:9957
|
-0.055x |
Annual Cash Flow Conversion Efficiency for Evolent Health Inc (2012–2025)
The table below shows the annual cash flow conversion efficiency of Evolent Health Inc from 2012 to 2025. Review EVH free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $415.19 Million | $38.84 Million | 0.094x | +399.18% |
| 2024-12-31 | $1.00 Billion | $18.77 Million | 0.019x | -85.97% |
| 2023-12-31 | $1.07 Billion | $142.58 Million | 0.134x | +1093.40% |
| 2022-12-31 | $859.42 Million | $-11.55 Million | -0.013x | -124.06% |
| 2021-12-31 | $693.63 Million | $38.75 Million | 0.056x | +313.32% |
| 2020-12-31 | $619.60 Million | $-16.23 Million | -0.026x | +42.95% |
| 2019-12-31 | $929.05 Million | $-42.65 Million | -0.046x | -164.36% |
| 2018-12-31 | $1.19 Billion | $-20.65 Million | -0.017x | +35.02% |
| 2017-12-31 | $1.05 Billion | $-27.96 Million | -0.027x | +31.36% |
| 2016-12-31 | $912.11 Million | $-35.51 Million | -0.039x | -83.49% |
| 2015-12-31 | $934.58 Million | $-19.83 Million | -0.021x | -100.06% |
| 2014-12-31 | $-2.07 Million | $-75.09 Million | 36.277x | +8363.21% |
| 2013-12-31 | $31.04 Million | $-13.63 Million | -0.439x | +82.12% |
| 2012-12-31 | $5.20 Million | $-12.77 Million | -2.455x | -- |
About Evolent Health Inc
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics an… Read more